Latest news
Merck lifts 2026 outlook as profits surge &Bio-Techne deal strengthens growth push - Indian Chemical NewsIndian Chemical News · Fri, 07 Aug 2026 08:49:06 GMTChip materials boom lifts Merck KGaA earnings, outlook - Communications TodayCommunications Today · Fri, 07 Aug 2026 03:15:35 GMTBoosted by new rare disease pillar, Merck KGaA lifts sales outlook for the year - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 19:16:57 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTMerck KGaA lifts guidance as bioprocessing and chips offset healthcare - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 18:05:32 GMTICON keeps lead as most active CRO in Q2 2026 - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 13:52:58 GMTActimed regains global rights to S-oxprenolol - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 13:52:58 GMTMerck Lifts Revenue View, Halves Profit Forecast - communitynews.orgcommunitynews.org · Thu, 06 Aug 2026 12:18:08 GMT